vers la météo de la validation par utilisateur
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------------COMP:N-N(of)---------------+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------------COMP:N-N(of)---------------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------------COMP:N-N(of)---------------+ | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------------COMP:N-N(of)---------------+ | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------------COMP:N-N(of)---------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------------COMP:N-N(of)---------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------------COMP:N-N(of)---------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------------COMP:N-N(of)---------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------------COMP:N-N(of)---------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+-----------------------------COMP:N-N(of)-----------------------------+ +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression)
+-----------------------------COMP:N-N(of)-----------------------------+ +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression)
+-----------------------------COMP:N-N(of)-----------------------------+ +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------------COMP:N-N(of)---------------+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------------COMP:N-N(of)---------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(of) (protein,serum) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------------COMP:N-N(of)---------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(of) (protein,serum) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------------COMP:N-N(of)---------------+ +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------------COMP:N-N(of)---------------+ | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------------COMP:N-N(of)---------------+ | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------------COMP:N-N(of)---------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(of) (protein,serum) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +---------------------------------------COMP:V-N(by)---------------------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ +COMP:V_PASS-N+COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+-----------------------------COMP:N-N(of)-----------------------------+ +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +---------------SUBJ:V-N---------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +---------------SUBJ:V-N---------------+ | | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | +COMP:V_PASS-N+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+---------------------------------------COMP:V-N(by)---------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,deprivation) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------COMP:N-N(by)---------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------------COMP:N-N(of)-------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------------COMP:N-N(of)-----------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(of) (__SP__,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(of)-------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------------COMP:N-N(of)---------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +---------------COMP:N-N(of)---------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------COMP:N-N(by)---------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) COMP:N-N(of) (protein,serum) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(of)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------------COMP:N-N(of)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(of)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(of)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------COMP:N-N(by)---------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------COMP:N-N(by)---------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------------COMP:N-N(of)-------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------------COMP:N-N(of)---------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------------COMP:N-N(of)---------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------------COMP:N-N(of)-----------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(of)-------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +---------------COMP:N-N(of)---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------COMP:N-N(by)---------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) COMP:N-N(of) (protein,serum) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------------COMP:N-N(of)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(of) (__SP__,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(of)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(of)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------------COMP:N-N(of)-----------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +---------------COMP:N-N(of)---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------COMP:N-N(by)---------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) COMP:N-N(of) (protein,serum) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------------COMP:N-N(of)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(of) (__SP__,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(of)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------COMP:N-N(by)---------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+-----------------------------COMP:N-N(of)-----------------------------+ +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ | +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +----------------------------------SUBJ:V-N----------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+-----------------------------COMP:N-N(of)-----------------------------+ +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------------OBJ:V-N----------------+ | +---------------SUBJ:V-N---------------+ | | | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------COMP:N-N(by)---------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +---------------COMP:N-N(of)---------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------COMP:N-N(by)---------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) COMP:N-N(of) (protein,serum) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------COMP:N-N(by)---------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------COMP:N-N(by)---------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------COMP:N-N(by)---------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------------COMP:N-N(of)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(of)-------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-----------------------COMP:N-N(of)-----------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------------COMP:N-N(of)-------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(of) (__NODE__,serum) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------------COMP:N-N(of)---------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) COMP:N-N(of) (protein,serum) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+-----------------------COMP:N-N(by)-----------------------+ +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +---------------SUBJ:V-N---------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)---------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+--SUBJ:V_PASS-N-+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+---------COMP:N-N(by)---------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) COMP:N-N(by) (protein,deprivation) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------------COMP:N-N(of)-----------------------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) SUBJ:V_PASS-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ +-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +----SUBJ:V-N----+-COMP:V-N(by)+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:V-N(by) (increase,deprivation)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:N-N(of) (deprivation,serum)
+-----------------------------COMP:N-N(of)-----------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +---------------SUBJ:V-N---------------+ | | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +----------------SUBJ:V_PASS-N---------------+ | | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+--------COMP:N-N(of)-------+ | | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,protein) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V_PASS-N (increase,expression)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------COMP:N-N(by)-----------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------COMP:N-N(by)-----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------COMP:N-N(by)-----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(of)-------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-------------------COMP:N-N(of)-------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------COMP:N-N(by)-------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------COMP:N-N(by)-------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------COMP:N-N(by)-----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(of)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | | +-------------COMP:N-N(by)-------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------COMP:N-N(by)-------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------COMP:N-N(by)-----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------COMP:N-N(by)-----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------COMP:N-N(by)-----------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------COMP:N-N(by)-----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------COMP:N-N(by)-----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | | +-----------------COMP:N-N(by)-----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------COMP:N-N(by)-----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(of)-------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(of)-------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------------COMP:N-N(of)-------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(of)-------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------COMP:N-N(by)-------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------------COMP:N-N(of)-------------------+ | | | +-----------------OBJ:V-N----------------+ | +-------------COMP:N-N(by)-------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------COMP:N-N(by)-----------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(of)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(of)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------COMP:N-N(by)-----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------COMP:N-N(by)-----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(of)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------COMP:N-N(by)-----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------COMP:N-N(by)-------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+---------OBJ:V-N--------+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | | +-------------COMP:N-N(by)-------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | | +-----------------COMP:N-N(by)-----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | | +-----------------COMP:N-N(by)-----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | | +-----------------COMP:N-N(by)-----------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------------COMP:N-N(of)-----------------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ | +-----------------------COMP:N-N(by)-----------------------+ | | | | | +-----------COMP:N-N(of)----------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) COMP:N-N(of) (mg/l,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-------------COMP:N-N(by)-------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------COMP:N-N(by)-----------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------COMP:N-N(by)-------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------COMP:N-N(by)-----------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ | +-----------------COMP:N-N(by)-----------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-------------------COMP:N-N(of)-------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-------------COMP:N-N(by)-------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) COMP:N-N(of) (__NODE__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------COMP:N-N(by)-----------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------COMP:N-N(by)-----------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | +-------------COMP:N-N(by)-------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ | +-------------COMP:N-N(by)-------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +---------OBJ:V-N--------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) MOD_POST:N-ADJ (__SP__,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ | +MOD_ATT+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(of)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) COMP:N-N(of) (__SP__,serum) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | +-----------------COMP:N-N(by)-----------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +-SUBJ:V-N-+ | +COMP:N-N(of+ | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein) COMP:N-N(of) (deprivation,serum)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +----COMP:N-N(of)---+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ | +MOD_ATT+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | +---COMP:N-N(from)---+ | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ +----SUBJ:V-N----+ | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,skin) MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | | +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ | +-----------------COMP:N-N(by)-----------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-------------OBJ:V-N------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | | +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+MOD_POS+ +-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) COMP:N-N(by) (__SP__,deprivation) SUBJ:V-N (be,protein) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+ +-----------------COMP:N-N(by)-----------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +-------------OBJ:V-N------------+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(of) (expression,serum) COMP:N-N(by) (__SP__,deprivation) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +----------------------------------------COMP:V-N(from)---------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +----------------------------------SUBJ:V-N----------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | | | +MOD_A+ | | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . MOD_ATT:N-ADJ (skin,__SP__) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,skin) SUBJ:V-N (decrease,hydroxycholesterol) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ | +----SUBJ:V-N----+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+-SUBJ:V-N-+ | | | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) SUBJ:V-N (be,protein) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | +COMP:N-N(from)+ +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ +MOD_ATT+----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_ATT:N-ADJ (protein,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-----------------------COMP:N-N(by)-----------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +-------------------OBJ:V-N------------------+ | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+MOD_POS+ +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) MOD_POST:N-ADJ (__SP__,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | | +COMP:N-N(from)+ +------APPOS-----+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_+ +COMP:N-N(of+ | +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . COMP:N-N(from) (fibroblast,__SP__) APPOS (skin,hydroxycholesterol) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------------COMP:V-N(from)------------------------------------------+ +-----------------------------COMP:N-N(of)-----------------------------+ | | +-------------------------------------------SUBJ:V-N------------------------------------------+ +-----------------------COMP:N-N(by)-----------------------+ | | | | +-----------------OBJ:V-N----------------+ +------------OBJ:V-N------------+-------------------OBJ:V-N------------------+ | | | | | +------OBJ:V-N-----+ +COMP:N-N(of+ +----COMP:V-N(by)---+ +---MOD_POST:N-ADJ--+ | | | | | +APPOS+ | +COMP:N+ | +MOD_ATT:+ +MOD+ | +MOD_ATT+ +COMP:N-N(of+ | +----SUBJ:V-N----+ | | | | | | | | | | | | | | | | | | | | | | | | In fibroblasts from __SP__ skin , 25 hydroxycholesterol ( with a dosage of 5 mg/l and a treatment period of 24 hours ) decreases ( by 50 90 percent ) expression of __SP__ __NODE__ protein that is increased by deprivation of serum . APPOS (skin,@card@) OBJ:V-N (with,mg/l) OBJ:V-N (with,period) COMP:N-N(of) (dosage,5) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (decrease,fibroblast) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,skin) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,expression) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (expression,__SP__) MOD_POST:N-ADJ (expression,__NODE__) COMP:N-N(by) (expression,deprivation) COMP:N-N(of) (expression,serum) OBJ:V-N (increase,expression) SUBJ:V-N (increase,protein)
